Concepedia

Tomonori Yamasaki

TY

Statistics

Publications

5

Citations

242

H-Index

5

Active since

2003

Affiliations

Daiichi-Sankyo (Japan)(Current)

Tomonori Yamasaki is an author at Daiichi-Sankyo (Japan) specializing in medicinal chemistry, pharmacy, and pharmacology.

Publications per year

2003–2017

5

Publications

5

Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor

Daisuke Honma, Osamu Kanno, Jun Watanabe et al. · Cancer Science · 2017 · 139 citations · Full text

, , +17

Reduction of Peptide Character of HIV Protease Inhibitors That Exhibit Nanomolar Potency against Multidrug Resistant HIV-1 Strains

Hirokazu Tamamura, Yasuhiro Koh, Satoshi Ueda et al. · Journal of Medicinal Chemistry · 2003 · 44 citations · Full text

, , +17

Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: Exploration of effective compounds in arthritis models

H. Shimizu, Tomonori Yamasaki, Yoshiyuki Yoneda et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 24 citations · Full text

, , +13

Discovery of imidazo[1,2-b]pyridazine derivatives as IKKβ inhibitors. Part 1: Hit-to-lead study and structure–activity relationship

H. Shimizu, Shinji Tanaka, Tadashi Toki et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 18 citations · Full text

, , +15

Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 2: Improvement of potency in vitro and in vivo

H. Shimizu, Isao Yasumatsu, Tomoaki Hamada et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 17 citations · Full text

, , +8

1–5 of 5